Advanced search

Personalized medicine in oncology, the potential role of nuclear medicine imaging

Christophe Van De Wiele (UGent) and Gilles Mees (UGent)
(2014) CURRENT PHARMACEUTICAL DESIGN. 20(14). p.2231-2233
Author
Organization
Keywords
CANCER, THERAPY, PET, PROGRESSION, INTEGRATION, AGENTS

Citation

Please use this url to cite or link to this publication:

Chicago
Van De Wiele, Christophe, and Gilles Mees. 2014. “Personalized Medicine in Oncology, the Potential Role of Nuclear Medicine Imaging.” Current Pharmaceutical Design.
APA
Van De Wiele, Christophe, & Mees, G. (2014). Personalized medicine in oncology, the potential role of nuclear medicine imaging. CURRENT PHARMACEUTICAL DESIGN.
Vancouver
1.
Van De Wiele C, Mees G. Personalized medicine in oncology, the potential role of nuclear medicine imaging. CURRENT PHARMACEUTICAL DESIGN. 2014. p. 2231–3.
MLA
Van De Wiele, Christophe, and Gilles Mees. “Personalized Medicine in Oncology, the Potential Role of Nuclear Medicine Imaging.” CURRENT PHARMACEUTICAL DESIGN 2014 : 2231–2233. Print.
@misc{4265877,
  author       = {Van De Wiele, Christophe and Mees, Gilles},
  issn         = {1381-6128},
  keyword      = {CANCER,THERAPY,PET,PROGRESSION,INTEGRATION,AGENTS},
  language     = {eng},
  number       = {14},
  pages        = {2231--2233},
  series       = {CURRENT PHARMACEUTICAL DESIGN},
  title        = {Personalized medicine in oncology, the potential role of nuclear medicine imaging},
  volume       = {20},
  year         = {2014},
}

Web of Science
Times cited: